🫀 SPIRIT-HF at #ACC26: Spironolactone, an aldosterone blocker, compared with placebo, did not show any significant improvement in terms of HF hospitalizations and cardiovascular death at 24 months in patients with #HFpEF or #HFmrEF.
See the results ➡️ https://bit.ly/4cbiPeW #HeartFailure #CardioSky
JAMA Cardiology: Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure. Figure 1 and 2 show cubic splines depicting trajectories in the period preceding sudden death. NYHA class and KCCQ-TSS graphs are displayed.
In #HFmrEF/#HFpEF, sudden death was usually preceded by modest worsening of symptoms, declining quality of life, and rising NT-proBNP, similar to other causes of death, limiting prediction specificity.
#ACC26 @accintouch.bsky.social
ja.ma/41tWm6G
The US FDA has approved Bayer’s Kerendia (finerenone) for adults with heart failure and left ventricular ejection fraction (LVEF) of 40% or higher.
#news #KERENDIA #HeartFailure #HFpEF #HFmrEF #Cardiology #HeartHealth #FDAApproval #PharmaNews #DrugApproval
The US FDA has approved Bayer’s Kerendia (finerenone) for adults with heart failure and left ventricular ejection fraction (LVEF) of 40% or higher.
#news #KERENDIA #HeartFailure #HFpEF #HFmrEF #Cardiology #HeartHealth #FDAApproval #PharmaNews #DrugApproval
Epicardial Adipose Tissue is associated with adverse prognosis in patients with #HFpEF & #HFmrEF: A Multicenter Study
#CardioSky #MedSky
#JAHA
@ahajournals.bsky.social @drmarthagulati.bsky.social @vietheartpa.bsky.social
www.ahajournals.org/doi/10.1161/...
DAPA ECHO trial : Beneficial effect of #dapagliflozin in nondiabetic patients with #HFrEF and #HFmrEF by speckle tracking #EchoFirst
www.jacc.org/doi/full/10.... @jaccjournals.bsky.social @jgrapsa.bsky.social @docstrom.bsky.social @purviparwani.bsky.social
